Bartlett & Co. LLC
- SEC CIK
- 0001550075
- Latest filing
- Jan 8, 2024
REGN holding history
Regeneron Pharmaceuticals, Inc. in every 13F filed by Bartlett & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
REGN overviewAll 13F holders of REGNFull Q4 2023 holdings
- Shares (Q4 2023)
- 344
- Value
- $303.0K
- % of portfolio
- <0.1%
- Quarters held
- 12
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 344 | $303.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 344 | $283.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 344 | $247.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 344 | $283.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 344 | $248.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 344 | $237.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 344 | $203.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 344 | $240.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 344 | $217.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 344 | $208.0K | <0.1% | −9−2.5% | Reduced | Holders |
| Q2 2021 | 353 | $197.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 353 | $167.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.